Northern Trust’s Avadel Pharmaceuticals AVDL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.43M Buy
839,117
+199,251
+31% +$1.76M ﹤0.01% 2232
2025
Q1
$5.01M Sell
639,866
-18,716
-3% -$147K ﹤0.01% 2400
2024
Q4
$6.92M Buy
658,582
+66,948
+11% +$704K ﹤0.01% 2333
2024
Q3
$7.76M Buy
+591,634
New +$7.76M ﹤0.01% 2219
2021
Q2
Sell
-20,781
Closed -$188K 4592
2021
Q1
$188K Sell
20,781
-238
-1% -$2.15K ﹤0.01% 4130
2020
Q4
$140K Sell
21,019
-581
-3% -$3.87K ﹤0.01% 4046
2020
Q3
$109K Sell
21,600
-63
-0.3% -$318 ﹤0.01% 3946
2020
Q2
$175K Buy
21,663
+6,744
+45% +$54.5K ﹤0.01% 3792
2020
Q1
$118K Sell
14,919
-691
-4% -$5.47K ﹤0.01% 3787
2019
Q4
$118K Sell
15,610
-50
-0.3% -$378 ﹤0.01% 3904
2019
Q3
$65K Buy
15,660
+14
+0.1% +$58 ﹤0.01% 4012
2019
Q2
$45K Sell
15,646
-1,178
-7% -$3.39K ﹤0.01% 4096
2019
Q1
$24K Sell
16,824
-360
-2% -$514 ﹤0.01% 4114
2018
Q4
$44K Sell
17,184
-352
-2% -$901 ﹤0.01% 4068
2018
Q3
$77K Buy
17,536
+2,063
+13% +$9.06K ﹤0.01% 4070
2018
Q2
$95K Buy
15,473
+1,602
+12% +$9.84K ﹤0.01% 4028
2018
Q1
$101K Sell
13,871
-301
-2% -$2.19K ﹤0.01% 3974
2017
Q4
$116K Sell
14,172
-534
-4% -$4.37K ﹤0.01% 3941
2017
Q3
$154K Sell
14,706
-342
-2% -$3.58K ﹤0.01% 3856
2017
Q2
$166K Sell
15,048
-961
-6% -$10.6K ﹤0.01% 3856
2017
Q1
$155K Buy
+16,009
New +$155K ﹤0.01% 3859
2015
Q2
Sell
-4,050
Closed -$73K 4240
2015
Q1
$73K Hold
4,050
﹤0.01% 4102
2014
Q4
$69K Buy
4,050
+1,975
+95% +$33.6K ﹤0.01% 4050
2014
Q3
$30K Sell
2,075
-15,233
-88% -$220K ﹤0.01% 4188
2014
Q2
$260K Buy
+17,308
New +$260K ﹤0.01% 3771